Antibasal ganglia antibodies, immunomodulation, and antibiotics in "poststreptococcal" adult neuropsychiatric disorders: not yet ready for "prime time".

MLA

Teixeira, Antonio L., et al. “Antibasal Ganglia Antibodies, Immunomodulation, and Antibiotics in ‘Poststreptococcal’ Adult Neuropsychiatric Disorders: Not yet Ready for ‘Prime Time.’” Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology, vol. 21, no. 2, June 2008, pp. 124–25. EBSCOhost, https://doi.org/10.1097/WNN.0b013e3181734319.

APA

Teixeira, A. L., Fontenelle, L. F., Mendlowicz, M. V., & Lauterbach, E. C. (2008). Antibasal ganglia antibodies, immunomodulation, and antibiotics in “poststreptococcal” adult neuropsychiatric disorders: not yet ready for “prime time.” Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology, 21(2), 124–125. https://doi.org/10.1097/WNN.0b013e3181734319

Chicago

Teixeira, Antonio L, Leonardo F Fontenelle, Mauro V Mendlowicz, and Edward C Lauterbach. 2008. “Antibasal Ganglia Antibodies, Immunomodulation, and Antibiotics in ‘Poststreptococcal’ Adult Neuropsychiatric Disorders: Not yet Ready for ‘Prime Time.’” Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology 21 (2): 124–25. doi:10.1097/WNN.0b013e3181734319.